| Date Filed | Type | Description |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 06/28/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/28/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 05/25/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Quarterly results |
| 03/28/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/15/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/15/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/14/2023 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 3.1% stake in WEST PHARMACEUTICAL SERVICES |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/27/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/27/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/28/2022 |
8-K
| Quarterly results |
| 07/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/23/2022 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/23/2022 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 05/26/2022 |
SD
| Form SD - Specialized disclosure report: |
| 05/26/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/28/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 04/14/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/01/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/28/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/17/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
|